SAN

Sanofi News

Name Symbol Markt Aktientyp
Sanofi SAN Euronext Ordinary Share
  Änderung Änderung % Aktuell Zeit
0,36 0,45% 80,37 17:40:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
80,47 79,85 80,72 80,37 80,01
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
30.9.202221:11DJNCorrection to Sanofi and Regeneron Pharmaceuticals Article..
29.9.202201:05DJNSanofi, Regeneron Say Dupixent Gets FDA Approval to Treat..
29.9.202200:05GLOBECommuniqué de presse: Dupixent® (dupilumab), premier et seul..
28.9.202207:30GLOBECommuniqué de presse : Mise en ligne du document «Q3 2022..
16.9.202208:45DJNAstraZeneca Says Nirsevimab Recommended for Approval in EU
16.9.202208:00GLOBECommuniqué de presse: Le CHMP recommande l’approbation de..
13.9.202221:24GLOBESanofi: Information concerning the total number of voting..
08.9.202217:30GLOBEPress Release: Dupixent® (dupilumab) late-breaking Phase 3..
31.8.202220:30GLOBEPress Release: XenpozymeTM (olipudase alfa-rpcp) approved by..
30.8.202208:28DJNSanofi Hemophilia Drug Granted Priority Review by U.S. FDA
30.8.202207:30GLOBEPress Release: FDA grants priority review to efanesoctocog..
17.8.202214:02DJNTrending: Sanofi Stops Development of Breast-Cancer Drug..
17.8.202210:15DJNSanofi Shares Drop After End of Development Program for..
17.8.202208:39DJNSanofi Stops Development Program for Breast-Cancer Treatment..
17.8.202207:30GLOBECommuniqué de presse: Sanofi fait le point sur le programme..
12.8.202210:48DJNGSK, Sanofi, Haleon Shares Recover Some Recent Losses After..
12.8.202209:30DJNHaleon Says It Hasn't Been Notified About Litigation on..
10.8.202221:29DJNSanofi Down Nearly 8%, On Track for Largest Percent Decrease..
08.8.202221:03GLOBESanofi: Information concerning the total number of voting..
04.8.202218:36DJNSanofi, Innovent Biologics to Collaborate on Oncology..
04.8.202217:30GLOBECommuniqué de presse : Sanofi et Innovent Biologics nouent..
28.7.202214:29GLOBEPress Release: Online availability of Sanofi’s half-year..
28.7.202208:05DJNSanofi Upgrades Fiscal Year Guidance as 2Q Sales Rose 16%
28.7.202207:30GLOBEPress Release: Strong execution in Q2 drives full-year 2022..
20.7.202218:52GLOBESanofi: Informations relatives au nombre de droits de vote..
14.7.202207:00GLOBECommuniqué de presse: Résultats positifs de phase III pour..
10.7.202215:45GLOBEPress Release: Pivotal data demonstrate once-weekly..
04.7.202212:00GLOBESanofi Global Health launches nonprofit Impact® brand for 30..
30.6.202217:42DJNSanofi on Pace for Largest Percent Decrease Since April 2020..
30.6.202212:29DJNSanofi's Phase 3 Trials of Multiple Sclerosis Drug Partially..
28.6.202207:30GLOBECommuniqué de presse: Nexviadyme® (avalglucosidase alpha),..
27.6.202222:57GLOBESanofi: Informations relatives au nombre de droits de vote..
24.6.202220:05DJNSanofi On Pace for Largest Percent Increase Since November..
24.6.202208:21DJNSanofi, GSK Report Successful Vaccine Study Against Omicron
24.6.202207:32GLOBEAvailability of the Q2 2022 Memorandum for modelling..
24.6.202207:28GLOBEPress Release: Sanofi-GSK first to report a successful..
13.6.202208:43DJNSanofi-GSK Covid-19 Booster Showing Strong Immune Response,..
13.6.202207:30GLOBEPress Release: Sanofi-GSK next-generation COVID-19 booster..
08.6.202211:21GLOBESanofi lance son premier Accélérateur digital porté par de..
08.6.202208:04DJNSanofi Gets U.S. FDA Nod on Use of Dupixent in Children With..
07.6.202222:45GLOBEPress Release: FDA approves Dupixent® (dupilumab) as first..
07.6.202207:30GLOBESanofi lance son plan mondial 2022 d’actionnariat salarié..
03.6.202217:21DJNImmunocore Shares Rise 10% on Collaboration With Sanofi
02.6.202219:48GLOBESanofi: Information concerning the total number of voting..
02.6.202214:19DJNRegeneron to Buy Sanofi's Stake in Libtayo Program
02.6.202213:30GLOBECommuniqué de presse: Sanofi accorde à Regeneron les droits..
01.6.202207:52DJNSanofi: U.S. FDA Gives Authorization to Expedite Development..
01.6.202207:00GLOBECommuniqué de presse: La FDA accorde la désignation de «..
31.5.202207:00GLOBECommuniqué de presse: La FDA accorde un examen prioritaire à..
30.5.202207:30GLOBEPress Release: Update on Cialis® Rx-to-OTC Switch Actual Use..
Kürzlich von Ihnen besucht
EU
SAN
Sanofi
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Melden Sie sich bei ADVFN an
Jetzt registrieren

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

P: V: D:20221005 20:49:06